» Articles » PMID: 25148104

Structural Basis for the Inhibition of HSP70 and DnaK Chaperones by Small-molecule Targeting of a C-terminal Allosteric Pocket

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2014 Aug 23
PMID 25148104
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The stress-inducible mammalian heat shock protein 70 (HSP70) and its bacterial orthologue DnaK are highly conserved nucleotide binding molecular chaperones. They represent critical regulators of cellular proteostasis, especially during conditions of enhanced stress. Cancer cells rely on HSP70 for survival, and this chaperone represents an attractive new therapeutic target. We have used a structure-activity approach and biophysical methods to characterize a class of inhibitors that bind to a unique allosteric site within the C-terminus of HSP70 and DnaK. Data from X-ray crystallography together with isothermal titration calorimetry, mutagenesis, and cell-based assays indicate that these inhibitors bind to a previously unappreciated allosteric pocket formed within the non-ATP-bound protein state. Moreover, binding of inhibitor alters the local protein conformation, resulting in reduced chaperone-client interactions and impairment of proteostasis. Our findings thereby provide a new chemical scaffold and target platform for both HSP70 and DnaK; these will be important tools with which to interrogate chaperone function and to aid ongoing efforts to optimize potency and efficacy in developing modulators of these chaperones for therapeutic use.

Citing Articles

SMR peptide antagonizes biofilm formation.

Huang M, Brena D, Wu J, Shelton M, Bond V Microbiol Spectr. 2024; 12(2):e0258323.

PMID: 38170991 PMC: 10846015. DOI: 10.1128/spectrum.02583-23.


CFTR Folding: From Structure and Proteostasis to Cystic Fibrosis Personalized Medicine.

McDonald E, Meiler J, Plate L ACS Chem Biol. 2023; 18(10):2128-2143.

PMID: 37730207 PMC: 10595991. DOI: 10.1021/acschembio.3c00310.


HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances.

Zhao K, Zhou G, Liu Y, Zhang J, Chen Y, Liu L Biomolecules. 2023; 13(4).

PMID: 37189349 PMC: 10136146. DOI: 10.3390/biom13040601.


Heat shock proteins and cancer: The FoxM1 connection.

Alimardan Z, Abbasi M, Hasanzadeh F, Aghaei M, Khodarahmi G, Kashfi K Biochem Pharmacol. 2023; 211:115505.

PMID: 36931349 PMC: 10134075. DOI: 10.1016/j.bcp.2023.115505.


Non-Equilibrium Protein Folding and Activation by ATP-Driven Chaperones.

Xu H Biomolecules. 2022; 12(6).

PMID: 35740957 PMC: 9221429. DOI: 10.3390/biom12060832.


References
1.
Mayer M, Schroder H, Rudiger S, Paal K, Laufen T, Bukau B . Multistep mechanism of substrate binding determines chaperone activity of Hsp70. Nat Struct Biol. 2000; 7(7):586-93. DOI: 10.1038/76819. View

2.
Bertelsen E, Chang L, Gestwicki J, Zuiderweg E . Solution conformation of wild-type E. coli Hsp70 (DnaK) chaperone complexed with ADP and substrate. Proc Natl Acad Sci U S A. 2009; 106(21):8471-6. PMC: 2689011. DOI: 10.1073/pnas.0903503106. View

3.
Kang Y, Taldone T, Patel H, Patel P, Rodina A, Gozman A . Heat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70. J Med Chem. 2014; 57(4):1188-207. PMC: 3983365. DOI: 10.1021/jm401551n. View

4.
Brodsky J, Chiosis G . Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators. Curr Top Med Chem. 2006; 6(11):1215-25. DOI: 10.2174/156802606777811997. View

5.
Patury S, Miyata Y, Gestwicki J . Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem. 2009; 9(15):1337-51. PMC: 2799686. DOI: 10.2174/156802609789895674. View